# The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes

> **NCT01762657** · PHASE3 · WITHDRAWN · sponsor: **Perle Bioscience, Inc.**

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Oral Cyclosporine and Oral Lansoprazole
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT01762657
- **Lead sponsor:** Perle Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped prior to Patient Enrollment
- **Last updated:** 2016-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762657, "The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01762657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*